VitaNova Life Sciences Corporation
VNOV
$4.83
-$2.67-35.60%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 745.40K | 862.80K | 859.60K | 850.70K | 218.30K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.60K | 2.90K | 5.80K | 6.60K | 6.00K |
| Change in Net Operating Assets | 118.20K | 298.80K | 95.10K | -664.50K | -701.80K |
| Cash from Operations | 865.20K | 1.16M | 960.60K | 192.80K | -477.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -99.00K | -125.00K | -52.60K | 0.00 | 74.90K |
| Total Debt Repaid | -3.00K | -3.00K | -3.00K | -3.00K | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 500.00 | 0.00 | 0.00 | 0.00 | -500.00 |
| Cash from Financing | -101.50K | -128.00K | -55.60K | -3.00K | 74.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 763.70K | 1.04M | 905.00K | 189.80K | -403.10K |